Core Viewpoint - The company Innotech has identified a range of home testing products that align well with current market demands, particularly in the context of respiratory and gastrointestinal infections, and is actively collaborating with major e-commerce platforms to enhance market presence [2]. Product Offerings - Innotech's product lineup includes: - Influenza A and B virus antigen test kits (colloidal gold method) - New coronavirus (2019-nCoV) antigen test kits (latex method) - Respiratory syncytial virus, adenovirus, parainfluenza virus antigen combination test kits (latex chromatography method) - Group A rotavirus, adenovirus, norovirus antigen test kits (latex chromatography method) - Fecal occult blood (FOB) test kits (colloidal gold immunochromatography method) - Helicobacter pylori antigen test kits (latex method) [2]. Market Development - The home testing market is experiencing rapid growth, driven by improvements in regulatory frameworks and clinical guidelines, indicating a promising application market for home testing products [2]. E-commerce Collaboration - The company has established partnerships with major e-commerce platforms such as JD.com, Tmall, and Meituan by setting up official flagship stores to enhance product accessibility [2].

Core Viewpoint - The company, Innotech (688253.SH), has recently obtained a new product qualification for a Helicobacter pylori antigen detection kit, which enhances its product range and market competitiveness [1] Product Qualification - The newly acquired product is a Helicobacter pylori antigen detection kit (latex method) with registration number 20253402376 [1] - The intended use of this product is for the qualitative detection of Helicobacter pylori antigen in human fecal samples, suitable for both professional medical personnel and consumer self-testing [1] Market Expansion - The acquisition of this qualification broadens the company's product offerings, thereby improving its market expansion capabilities and core competitiveness [1]

Core Viewpoint - InnoTech (688253.SH) has recently obtained a new product qualification for a Helicobacter pylori antigen detection kit, enhancing its product range and market competitiveness [1] Product Qualification - The newly acquired product is a Helicobacter pylori antigen detection kit (latex method) with registration number 20253402376 [1] - The intended use of this product is for the qualitative detection of Helicobacter pylori antigen in human fecal samples, suitable for both professional medical personnel in healthcare settings and for consumer self-testing [1] Market Expansion - The acquisition of this qualification broadens the company's product offerings, thereby improving its market expansion capabilities and core competitiveness [1]

Core Viewpoint - The company has recently obtained a new product qualification for a Helicobacter pylori antigen detection kit (latex method), which enhances its product range and market competitiveness, although the actual sales impact remains uncertain [1] Group 1: Product Qualification - The company has acquired a new product qualification for the Helicobacter pylori antigen detection kit, with registration number 国械注准20253402376 [1] - The certification was issued on November 25, 2025, and is valid until November 24, 2030 [1] - This product is intended for in vitro qualitative detection of Helicobacter pylori antigen in human fecal samples, suitable for both professional medical personnel and consumer self-testing [1] Group 2: Market Impact - The new qualification broadens the company's product offerings, potentially enhancing its market expansion and core competitiveness [1] - However, the actual sales performance of the product is influenced by various factors, making the impact on financial performance difficult to predict [1]